MedPath

METROGEL

These highlights do not include all the information needed to use METROGEL, 1% safely and effectively. See full prescribing information for METROGEL, 1% METROGEL® (metronidazole) topical gel Initial U.S. Approval 1963

Approved
Approval ID

ab3a8a2d-714a-4beb-af8a-99bc3ac3ebbe

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 27, 2023

Manufacturers
FDA

Galderma Laboratories, L.P.

DUNS: 047350186

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

metronidazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0299-3820
Application NumberNDA021789
Product Classification
M
Marketing Category
C73594
G
Generic Name
metronidazole
Product Specifications
Route of AdministrationTOPICAL
Effective DateNovember 22, 2023
FDA Product Classification

INGREDIENTS (9)

METRONIDAZOLEActive
Quantity: 10 mg in 1 g
Code: 140QMO216E
Classification: ACTIB
methylparabenInactive
Code: A2I8C7HI9T
Classification: IACT
betadexInactive
Code: JV039JZZ3A
Classification: IACT
edetate disodiumInactive
Code: 7FLD91C86K
Classification: IACT
propylparabenInactive
Code: Z8IX2SC1OH
Classification: IACT
niacinamideInactive
Code: 25X51I8RD4
Classification: IACT
phenoxyethanolInactive
Code: HIE492ZZ3T
Classification: IACT
propylene glycolInactive
Code: 6DC9Q167V3
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

METROGEL - FDA Drug Approval Details